| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |